INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,889,773 | -28.9% | 36,279 | -13.6% | 0.02% | -40.6% |
Q2 2023 | $2,657,920 | +13.9% | 41,976 | -16.3% | 0.03% | -36.0% |
Q3 2022 | $2,334,000 | +118.3% | 50,158 | +167.8% | 0.05% | +78.6% |
Q2 2022 | $1,069,000 | +53.6% | 18,727 | +0.3% | 0.03% | +154.5% |
Q3 2021 | $696,000 | +50.3% | 18,678 | -41.6% | 0.01% | -8.3% |
Q4 2017 | $463,000 | -51.1% | 31,965 | -46.7% | 0.01% | -50.0% |
Q3 2017 | $947,000 | -61.0% | 59,991 | -1.1% | 0.02% | -70.7% |
Q3 2015 | $2,428,000 | +567.0% | 60,637 | +203.2% | 0.08% | +446.7% |
Q1 2014 | $364,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |